พบ "Public health policy"ทั้งหมด 1,272 ผลลัพธ์
เรียงลำดับตาม
วันที่อัปเดตล่าสุด

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. (2010)

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. Pattara Leelahavarong1,2, Usa Chaikledkaew1,2*, Suradej Hongeng3, Vijj Kasemsup4, Yoel Lubell1,5, Yot Teerawattananon1 1Health Intervention and Technolog

Scaling up health policies and services in low- and middle-income settings. (2010)

Scaling up health policies and services in low- and middle-income settings. Kara Hanson1*, Susan Cleary2, Helen Schneider3, Sripen Tantivess4, Lucy Gilson1,5 1Department of Global Health and Development, London School of Hygiene and Tropical Medicine, UK. 2Health Economics Unit, University of Cap

ISPOR 2008 International Fellowship Report: Is it Time to Think Seriously About Making HTA Available in Settings Where There is the Most Need? (2010)

ISPOR 2008 International Fellowship Report: Is it Time to Think Seriously About Making HTA Available in Settings Where There is the Most Need? Yot Teerawattananon Health Intervention and Technology Assessment Program, Department of Health, Ministry of Public Health, Nonthaburi, Thailand Int

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand. (2010)

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand. Pattanaphesaj J, Teerawattananon Y.  Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand Backgroud: Following universal access to antiretroviral

12th HTAsiaLink Newsletter: GEAR4Health, a global platform for economic evaluations in LMICs

Economic evaluation (EE) is a field that is increasingly needed in many countries to support health decision making for priority setting and resource allocation. Although the core concept of EE is simple it is a comparison of at least 2 interventions in terms of costs and benefits – the practicaliti

11th HTAsiaLink Newsletter: HIGH-COST DRUGS

Change is good. Health Technology Assessment itself is constituted of many change components starting from research, which is looking for evidence to change something, to decision-making, which is changing something from its previous state to a new one. With the half of 2017 gone by, many new change

13th HTAsiaLink Newletter: HTA and Priority Setting

In the era that most of the countries are moving toward universal health coverage (UHC), there is no doubt that every country experiences gap between their citizen’s health needs and what is economically achievable by government, especially in speedily advancement in health technology field. Hence p

16th HTAsiaLink Newsletter: Lessons from the Pandemic for HTA

The past 9th HTAsiaLink Annual Conference has been a big success, initiating the first hybrid conference in our HTAsiaLink history. However, unpredictable challenges still await, both existing and new coming issues. Omicron is one of them, provoking us to strive for more knowledge and evidence. As f

18th HTAsiaLink Newsletter: The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions

The 10th HTAsiaLink Annual Conference is the first physical conference after the pandemic hit for HTAsiaLink network. Under the theme ‘The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions,’ a broad range of discussions were sparked and would co

17th HTAsiaLink Newsletter: Bridge to the Future – Horizon Scanning for Emerging Health Technology

In the world that is full of unpredictable and countless number of uncertainties, it is a great challenge that we have to observe and adapt in order to overcome such swiftly shifting challenges. However, over the past three years, people around the world have been facing one of the most critic
10 / หน้า